Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(4); doi: 10.25236/IJFM.2022.040401.

ITGB1 promotes apoptosis in H9C2 cells

Author(s)

Weizhe Liu1, Juanjuan Zhang2,3, Aiying Li1,2

Corresponding Author:
Aiying Li
Affiliation(s)

1Department of Biochemistry and Biology, College of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China

2Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Shijiazhuang, China

3Key Laboratory for Health Care with Chinese Medicine of Hebei Province, Shijiazhuang, China

Abstract

Myocardial infarction is a heart disease with high mortality rate. The research on the cardiomyocyte apoptosis is helpful to the prevention and treatment of myocardial infarction. As a cell surface receptor, the function of ITGB1 gene in cardiomyocytes is not clear. This study aimed to analyze the function and molecular mechanism of cardiomyocyte derived ITGB1 in myocardial apoptosis. To analyze cardiomyocyte apoptosis, TUNEL staining was performed with ITGB1 overexpression and knockdown in H9C2 cells. Apoptosis-related markers were also detected using Western blot. In addition, apoptosis-related signaling pathways were detected to elucidate the molecular mechanism regulated by ITGB1. Our results indicated that ITGB1 promoted cardiomyocyte apoptosis by inhibiting the Notch1 and Smad2/3 signal pathways. These data highlight the potential usefulness of ITGB1 as a potential target for preventing myocardial infarction.

Keywords

ITGB1, H9C2 cells, Cardiomyocyte apoptosis, Myocardial infarction

Cite This Paper

Weizhe Liu, Juanjuan Zhang, Aiying Li. ITGB1 promotes apoptosis in H9C2 cells. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 4: 1-8. https://doi.org/10.25236/IJFM.2022.040401.

References

[1] Grant W Reed, Jeffrey E Rossi and Christopher P Cannon. (2017) Acute myocardial infarction. Lancet. 389: 197-210. 

[2] Fahad Alqahtani, Sami Aljohani, Abdul Tarabishy, Tatiana Busu, Amelia Adcock and Mohamad Alkhouli. (2017) Incidence and Outcomes of Myocardial Infarction in Patients Admitted With Acute Ischemic Stroke. Stroke. 48: 2931-2938. 

[3] Adriana D Adameova, Sukhwinder K Bhullar, Vijayan Elimban and Naranjan S Dhalla. (2018) Activation of β(1)-adrenoceptors may not be involved in arrhythmogenesis in ischemic heart disease. Rev Cardiovasc Med. 19: 97-101. 

[4] Lennart Nilsson, Aleksander Szymanowski, Eva Swahn and Lena Jonasson. (2013) Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS One. 8: e55477. 

[5] A Abbate, R Melfi, G Patti, F Baldi, A D'Ambrosio, A Manzoli, A Baldi and G Di Sciascio. (2000) Apoptosis in recent myocardial infarction. Clin Ter. 151: 247-51. 

[6] Yan Dong, Hengwen Chen, Jialiang Gao, Yongmei Liu, Jun Li and Jie Wang. (2019) Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol. 136: 27-41. 

[7] T Ohtsuka, M Hamada, O Sasaki, M Suzuki, Y Hara, Y Shigematsu, T Ohtani, T Honda and K Hiwada. (1999) Clinical implications of circulating soluble Fas and Fas ligand in patients with acute myocardial infarction. Coron Artery Dis. 10: 221-5. 

[8] Luo, K.Q, H.B. Long and B.C. Xu. (2015) Reduced apoptosis after acute myocardial infarction by simvastatin. Cell Biochem Biophys. 71: 735-40. 

[9] Gahmberg, C.G. and M. Grönholm. (2021) How integrin phosphorylations regulate cell adhesion and signaling. Trends Biochem Sci. 3, S0968-0004: 00242-5. DOI: 10.1016/j.tibs.2021.11.003

[10] Li Lei, Dinggang Liu, Yan Huang, Ion Jovin, Shaw-Yung Shai, Themis Kyriakides, Robert S Ross and Frank J Giordano. (2008) Endothelial expression of beta1 integrin is required for embryonic vascular patterning and postnatal vascular remodeling. Mol Cell Biol. 28: 794-802. 

[11] Hiroyuki Yamamoto, Manuel Ehling, Katsuhiro Kato, Kenichi Kanai, Max van Lessen, Maike Frye, Dagmar Zeuschner, Masanori Nakayama, Dietmar Vestweber and Ralf H Adams. (2015) Integrin β1 controls VE-cadherin localization and blood vessel stability. Nat Commun. 6: 6429. 

[12] Prasanna Krishnamurthy, Venkateswaran Subramanian, Mahipal Singh and Krishna Singh. (2007) Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension. 49: 865-72.  

[13] Carina Henning, Anna Branopolski, Paula Follert, Oksana Lewandowska, Aysel Ayhan, Marcel Benkhoff, Ulrich Flögel, Malte Kelm, Christian Heiss and Eckhard Lammert. (2021) Endothelial β1 Integrin-Mediated Adaptation to Myocardial Ischemia. Thromb Haemost. 121: 741-754. 

[14] Mughal W, Dhingra R and Kirshenbaum LA. (2012) Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep. 14: 540-7. 

[15] Bo Yang, Chang-Lin Lu, Hua Zhao and Ran Dong. (2021) Effects of Nano-Protein Complexes on Apoptosis of Myocardial Infarction Cells Based on Complex Curve Analysis. J Nanosci Nanotechnol. 21: 1272-1277. 

[16] Fen Zhu, Qing Li, Jun Li, Benlei Li and Dongsheng Li. (2021) Long noncoding Mirt2 reduces apoptosis to alleviate myocardial infarction through regulation of the miR-764/PDK1 axis. Lab Invest. 101: 165-176. 

[17] Jijing Fang, Weihong Zheng, Pengfei Hu and Jiale Wu. (2021) Investigating the effect of lncRNA HOTAIR on apoptosis induced by myocardial ischemia-reperfusion injury. Mol Med Rep. 23: 169. 

[18] Chunhua Liu, Dingyan Lu, Jingrui You, Yuan Lu, Jia Sun, Jie Pan, Yonglin Wang, Aimin Wang, Yanyu Lan, Yongjun Li and Ting Liu. (2021) Efficacy of water fraction from Dioscorea cirrhosa on oxidative stress and apoptosis in H9c2 cardiomyocytes induced by H2O2. J Tradit Chin Med. 41: 51-58. 

[19] Danhong Yu, Zengyan Zhu, Mei Wang, Xinyuan Ding, Huan Gui, Jin Ma, Yinghui Yan, Gang Li, Qiongming Xu, Wenjuan Wang and Chenmei Mao. (2021) Triterpenoid saponins from Ilex cornuta protect H9c2 cardiomyocytes against H2O2-induced apoptosis by modulating Ezh2 phosphorylation. J Ethnopharmacol. 6: 113691. 

[20] Z-F Ma, N Wang, J Zhang, Y-F Wan, N Xiao and C Chen. (2021) Overexpression of miR-431 inhibits cardiomyocyte apoptosis following myocardial infarction via targeting HIPK3. Eur Rev Med Pharmacol Sci. 25: 2056-2064. 

[21] Dan-Dan Zong, Xiang-Ming Liu, Jin-Hua Li, Ruo-Yun Ouyang, Ying-Jiao Long, Ping Chen and Yan Chen. (2021) Resveratrol attenuates cigarette smoke induced endothelial apoptosis by activating Notch1 signaling mediated autophagy. Respir Res. 22: 22. 

[22] Jiewei Lin, Zhiwei Xu, Junjie Xie, Xiaxing Deng, Lingxi Jiang, Hao Chen, Chenghong Peng, Hongwei Li, Jiaqiang Zhang and Baiyong Shen. (2021) Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer. Cell Death Dis. 2(12): 760. 

[23] Lin Zhang, Wei Wei, Xiaoyu Ai, Ertugrul Kilic, Dirk M Hermann, Vivek Venkataramani , Mathias Bähr and Thorsten R Doeppner. (2021) Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-beta/Smad2/3 pathway. Cell Death Dis. 9(12): 1068. 

[24] Jing Wang, Zhenyu Fan, Jia Li, Jingmao Yang, Xiaofei Liu and Jilin Cheng. (2021) Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-beta1 /Smad2/3 pathway. Bioengineered. 12: 3566-3577. 

[25] Mariano L Schuman, Ludmila S Peres Diaz, Maia Aisicovich, Fernando Ingallina, Jorge E Toblli, Maria S Landa and Silvia I García. (2021) Cardiac Thyrotropin-releasing Hormone Inhibition Improves Ventricular Function and Reduces Hypertrophy and Fibrosis After Myocardial Infarction in Rats. J Card Fail. 27: 796-807. 

[26] Obeng E. (2021) Apoptosis (programmed cell death) and its signals-A review. Braz J Biol. 81: 1133-1143. 

[27] D'Arcy MS. (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 43: 582-592. 

[28] Nakamura M and Sadoshima J. (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 15: 387-407.